NL7201692A - - Google Patents

Info

Publication number
NL7201692A
NL7201692A NL7201692A NL7201692A NL7201692A NL 7201692 A NL7201692 A NL 7201692A NL 7201692 A NL7201692 A NL 7201692A NL 7201692 A NL7201692 A NL 7201692A NL 7201692 A NL7201692 A NL 7201692A
Authority
NL
Netherlands
Application number
NL7201692A
Other versions
NL151709B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to DE2233682A priority Critical patent/DE2233682A1/de
Publication of NL7201692A publication Critical patent/NL7201692A/xx
Priority to JP3475673A priority patent/JPS5710106B2/ja
Priority to FR7311783A priority patent/FR2182925B2/fr
Priority to BE129585A priority patent/BE797705R/xx
Priority to US00372313A priority patent/US3856792A/en
Priority claimed from US00372313A external-priority patent/US3856792A/en
Priority to NL7605446.A priority patent/NL166471C/xx
Publication of NL151709B publication Critical patent/NL151709B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NL727201692A 1971-02-09 1972-02-09 Werkwijze ter bereiding van 6-fenyl-4 h-s-triazolo (4,3-a) (1,4) benzodiazepinen. NL151709B (nl)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE2233682A DE2233682A1 (de) 1971-02-09 1972-07-08 2- eckige klammer auf 3-(subst. aminomethyl)-4-h-1,2,4-triazol-4-yl eckige klammer zu -benzophenone, ein verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
JP3475673A JPS5710106B2 (en:Method) 1971-02-09 1973-03-28
FR7311783A FR2182925B2 (en:Method) 1971-02-09 1973-04-02
BE129585A BE797705R (fr) 1971-02-09 1973-04-03 Derives de benzodiazepines et leur preparation
US00372313A US3856792A (en) 1971-02-09 1973-06-21 2-{8 2-(substituted aminomethyl)-4h-1,2,4-triazol-4-yl{9 benzophenones
NL7605446.A NL166471C (nl) 1971-02-09 1976-05-21 Werkwijze ter bereiding van een therapeutisch preparaat alsmede werkwijze ter bereiding van een daarvoor ge- schikt benzofenonderivaat.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11404971A 1971-02-09 1971-02-09
US24075672A 1972-04-03 1972-04-03
US00372313A US3856792A (en) 1971-02-09 1973-06-21 2-{8 2-(substituted aminomethyl)-4h-1,2,4-triazol-4-yl{9 benzophenones

Publications (2)

Publication Number Publication Date
NL7201692A true NL7201692A (en:Method) 1972-08-11
NL151709B NL151709B (nl) 1976-12-15

Family

ID=27381433

Family Applications (1)

Application Number Title Priority Date Filing Date
NL727201692A NL151709B (nl) 1971-02-09 1972-02-09 Werkwijze ter bereiding van 6-fenyl-4 h-s-triazolo (4,3-a) (1,4) benzodiazepinen.

Country Status (14)

Country Link
US (1) US3709898A (en:Method)
JP (1) JPS4966679A (en:Method)
BE (1) BE779144A (en:Method)
BR (1) BR7200590D0 (en:Method)
CA (1) CA966123A (en:Method)
CH (2) CH569736A5 (en:Method)
DE (2) DE2203782C2 (en:Method)
DK (1) DK513578A (en:Method)
FR (1) FR2124559B1 (en:Method)
GB (4) GB1374825A (en:Method)
HK (1) HK2580A (en:Method)
NL (1) NL151709B (en:Method)
SE (1) SE414928B (en:Method)
ZA (1) ZA7251B (en:Method)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA995214A (en) * 1971-06-05 1976-08-17 Kanji Meguro Benzodiazepines
US3904641A (en) * 1971-06-18 1975-09-09 Yoshitomi Pharmaceutical Triazolothienodiazepine compounds
BE790838A (fr) * 1971-11-02 1973-04-30 Upjohn Co Nouvelles 1-aminophenyl-6-phenyl-s-triazolo (4,3-a) (1,4)- benzodiazepines, leur procede de preparation et medicament les contenant
CH587263A5 (en:Method) * 1973-02-14 1977-04-29 Upjohn Co
US3879413A (en) * 1973-02-14 1975-04-22 Upjohn Co Process for the production of 6-phenyl-4-H-s-triazolo {8 4,3-a{9 {8 1,4{9 benzodiazepines
US3842090A (en) * 1973-02-14 1974-10-15 Upjohn Co Certain 1-aminomethyl-6-phenyl 4h-s-triazolo(4,3-a)(1,4)benzodiazepines
US4263310A (en) * 1974-03-02 1981-04-21 Boehringer Ingelheim Gmbh 8-Bromo-6-(o-chloro-phenyl)-4H-S-triazolo-[3,4,-c]-thieno-[2,3-e]-1,4-diazepines and salts thereof
GB1517164A (en) * 1974-08-20 1978-07-12 Roche Products Ltd Substituted-phenyl ketones and a process for the manufacture thereof
US4000151A (en) * 1974-09-11 1976-12-28 The Upjohn Company Triazolyl benzophenone compounds
US4000153A (en) * 1974-09-26 1976-12-28 The Upjohn Company Triazolobenzodiazepine intermediates
CA1060892A (en) * 1974-11-06 1979-08-21 Parke, Davis And Company Diazepine compounds and method for their production
CH601267A5 (en:Method) * 1975-12-12 1978-06-30 Ciba Geigy Ag
US4105851A (en) * 1975-09-08 1978-08-08 Parke, Davis & Company 1,3,8-Trimethylimidazopyrazolodiazepine compounds
US4009175A (en) * 1976-03-15 1977-02-22 The Upjohn Company 1-[(Aminooxy)-methyl]-6-substituted-4H-s-triazolo[4,3-a][1,4] benzodiazepines
US4409390A (en) * 1981-07-23 1983-10-11 Hoffmann-La Roche Inc. Pyrrolo[3,4-D][2]Benzazepines
US4405518A (en) * 1981-07-23 1983-09-20 Hoffmann-La Roche Inc. Pyrrolo[3,4-d] [2] benzazepines
US4375473A (en) * 1982-01-04 1983-03-01 The Upjohn Company Method
US4501698A (en) * 1983-03-31 1985-02-26 The Upjohn Company Preparing 1-(hydroxymethyl)-triazolobenzodiazepines and 1-(aminomethyl)-triazolobenzodiazepines
MX373121B (es) 2010-05-14 2020-04-30 Dana Farber Cancer Inst Inc Composiciones y metodos para el tratamiento de leucemia.
US9301962B2 (en) 2010-05-14 2016-04-05 Baylor College Of Medicine Male contraceptive compositions and methods of use
MX384074B (es) 2010-05-14 2025-03-12 Dana Farber Cancer Inst Inc Composiciones y métodos para tratar neoplasias, enfermedades inflamatorias y otros trastornos.
AU2015201727B2 (en) * 2010-05-14 2018-03-08 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating neoplasia, inflammatory disease and other disorders
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2705039B1 (en) 2011-05-04 2017-07-26 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9328117B2 (en) 2011-06-17 2016-05-03 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9624244B2 (en) 2012-06-06 2017-04-18 Constellation Pharmaceuticals, Inc. Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
WO2015013635A2 (en) 2013-07-25 2015-01-29 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
EP3066101B1 (en) 2013-11-08 2020-07-29 Dana-Farber Cancer Institute, Inc. Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
EP3099677A4 (en) 2014-01-31 2017-07-26 Dana-Farber Cancer Institute, Inc. Diaminopyrimidine benzenesulfone derivatives and uses thereof
WO2015117087A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
KR20160130778A (ko) 2014-02-28 2016-11-14 텐샤 세러퓨틱스 인코포레이티드 고인슐린혈증과 관련된 질환의 치료
PL3157928T3 (pl) 2014-06-20 2019-07-31 Constellation Pharmaceuticals, Inc. Krystaliczne postacie 2-((4S)-6-(4-chlorofenylo)-1-metylo-4H-benzo[ c]izoksazolo-[4,5-e]azepin-4-ylo)acetamidu
EP3177626A4 (en) 2014-08-08 2017-12-27 Dana Farber Cancer Institute, Inc. Diazepane derivatives and uses thereof
MX2017001757A (es) 2014-08-08 2017-05-30 Dana Farber Cancer Inst Inc Derivados de dihidropteridinona y sus usos.
AU2015339511B2 (en) 2014-10-27 2020-05-14 Tensha Therapeutics, Inc. Bromodomain inhibitors
EP3307728A4 (en) 2015-06-12 2019-07-17 Dana Farber Cancer Institute, Inc. COMBINATION THERAPY OF TRANSCRIPTION INHIBITORS AND CHINESE INHIBITORS
PE20181287A1 (es) 2015-09-11 2018-08-07 Dana Farber Cancer Inst Inc Ciano tienotriazolpirazinas y usos de las mismas
UA123946C2 (uk) 2015-09-11 2021-06-30 Дана-Фарбер Кенсер Інстітьют, Інк. Ацетамідтієнотриазолодіазепіни й шляхи їх застосування
CA3003288A1 (en) 2015-11-25 2017-06-01 Dana-Farber Cancer Institute, Inc. Bivalent bromodomain inhibitors and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413346A (en) * 1966-01-19 1968-11-26 Hoffmann La Roche 2-(2-haloethylamino)-5-halo-benzophenones
US3987052A (en) * 1969-03-17 1976-10-19 The Upjohn Company 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
DE1955349C2 (de) * 1969-11-04 1982-01-28 Takeda Chemical Industries, Ltd., Osaka s-Triazolo [4,3-a] [1,4] benzodiazepine
YU34997B (en) * 1970-03-27 1980-06-30 Hiroyuki Tawada Process for preparing benzodiazepine derivatives

Also Published As

Publication number Publication date
NL151709B (nl) 1976-12-15
GB1374823A (en) 1974-11-20
GB1374825A (en) 1974-11-20
AU3772572A (en) 1973-07-12
US3709898A (en) 1973-01-09
CA966123A (en) 1975-04-15
ZA7251B (en) 1972-09-27
DE2203782A1 (de) 1972-08-24
GB1374822A (en) 1974-11-20
GB1374824A (en) 1974-11-20
DE2265617B2 (de) 1981-07-16
BE779144A (fr) 1972-08-09
HK2580A (en) 1980-01-25
CH569736A5 (en:Method) 1975-11-28
FR2124559B1 (en:Method) 1975-08-01
FR2124559A1 (en:Method) 1972-09-22
DK513578A (da) 1978-11-17
BR7200590D0 (pt) 1973-07-17
SE414928B (sv) 1980-08-25
DE2265617C3 (de) 1982-05-06
CH570404A5 (en:Method) 1975-12-15
DE2203782C2 (de) 1982-05-13
JPS4966679A (en:Method) 1974-06-27

Similar Documents

Publication Publication Date Title
FR2124559B1 (en:Method)
FR2137896A2 (en:Method)
DE2252374B2 (en:Method)
CS150046B1 (en:Method)
FR2123494A1 (en:Method)
DK133804C (en:Method)
FR2121467B2 (en:Method)
FR2083266A5 (en:Method)
FR2138555B1 (en:Method)
FR2124644A5 (en:Method)
FR2124753A7 (en:Method)
FR2121772A1 (en:Method)
FR2123190B1 (en:Method)
FR2123717A5 (en:Method)
CS167519B1 (en:Method)
FR2125268A1 (en:Method)
CS149129B1 (en:Method)
CS153122B1 (en:Method)
CS153811B1 (en:Method)
AU4958672A (en:Method)
CS151909B1 (en:Method)
CH572500A5 (en:Method)
BG17141A1 (en:Method)
CH1895572A4 (en:Method)
DD97316A1 (en:Method)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: UPJOHN